<?xml version="1.0" encoding="UTF-8" ?><rss xmlns:itunes="http://www.itunes.com/DTDs/Podcast-1.0.dtd" version="2.0"><channel><title>ANTISENSE THERAPEUTICS LIMITED Podcast via ABN Newswire</title><link>http://www.abnnewswire.net/podcast/en/28749/ANTISENSE_THERAPEUTICS_LIMITED</link><description>Portable audio versions of financial and company related announcements of interest to investors and analysts. More detailed / complete content can be found at ABN Newswire (http://www.abnnewswire.net)</description><language>en-us</language><copyright>Copyright 2004-2008, ABN Newswire</copyright><managingEditor>newsroom@abnnewswire.net</managingEditor><pubDate>Sun, 7 Sep 2008 06:25:48 +0900</pubDate><lastBuildDate>Sun, 7 Sep 2008 06:25:48 +0900</lastBuildDate><image><title>ABN Newswire</title><url>http://www.abnnewswire.net/images/logos/abnlogo.jpg</url><link>http://www.abnnewswire.net/index.asp</link><width>60</width><height>19</height><description>Asia Business News - ANTISENSE THERAPEUTICS LIMITED Podcast</description></image><itunes:author>ABN Newswire</itunes:author><itunes:subtitle>ABN Newswire Podcasts</itunes:subtitle><itunes:summary>Portable audio versions of financial and company related announcements of interest to investors and analysts. More detailed / complete content can be found at ABN Newswire (http://www.abnnewswire.net)</itunes:summary><copyright>Copyright 2007 ABN Newswire</copyright><itunes:owner><itunes:name>ABN Newswire</itunes:name><itunes:email>newsroom@abnnewswire.net</itunes:email></itunes:owner><itunes:image href="http://www.abnnewswire.net/images/logos/abnlogo.jpg" /><itunes:category text="Business" /><item><title>ANTISENSE THERAPEUTICS LIMITED  ASX: ANP - Commencement of Phase IIa Multiple Sclerosis Trial - Mr Mark Diamond, CEO</title><link>http://www.abnnewswire.net/companies/en/28749/ANTISENSE_THERAPEUTICS_LIMITED</link><itunes:author>ANTISENSE THERAPEUTICS LIMITED</itunes:author><itunes:subtitle>ANTISENSE THERAPEUTICS LIMITED (ASX: ANP...</itunes:subtitle><itunes:summary>ANTISENSE THERAPEUTICS LIMITED (ASX: ANP) - Commencement of Phase IIa Multiple Sclerosis Trial - Mr Mark Diamond, CEO; Boardroomradio is pleased to announce that ANTISENSE THERAPEUTICS LIMITED (ASX: ANP) has published an audio file. The following presentation &quot;Commencement of Phase IIa Multiple Sclerosis Trial&quot; is now available as an instant audio download to your computer. You may also transfer this information to your listening device as an IPod podcast.  The BRR service is based on ... more </itunes:summary><enclosure url="http://boardroom-pc.streamguys.us/files/ANP/ANP20060629.mp3" length="" type="audio/mpeg" /><guid>http://boardroom-pc.streamguys.us/files/ANP/ANP20060629.mp3</guid><pubDate>Thu, 29 Jun 2006 13:13:00 GMT+0900</pubDate><itunes:category text="Business" /><itunes:duration>00:10:00</itunes:duration><itunes:keywords>ANTISENSE THERAPEUTICS LIMITED</itunes:keywords></item></channel></rss>